GSK takes billion-dollar drug fight with Gilead to top AIDS meeting

LONDON (Reuters) – GlaxoSmithKline is taking its fight with Gilead Sciences for dominance of the HIV market to the world’s leading AIDS conference next month by showcasing detailed results from its new two-drug treatment.

Source: Reuters Health

Leave a Reply

Your email address will not be published. Required fields are marked *